{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T20:01:42Z","timestamp":1772827302499,"version":"3.50.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2007,10,9]],"date-time":"2007-10-09T00:00:00Z","timestamp":1191888000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2007,11]]},"DOI":"10.1038\/sj.bjc.6604014","type":"journal-article","created":{"date-parts":[[2007,10,9]],"date-time":"2007-10-09T13:49:32Z","timestamp":1191937772000},"page":"1425-1431","source":"Crossref","is-referenced-by-count":26,"title":["Genetic and epigenetic alterations of Ras signalling pathway in colorectal neoplasia: analysis based on tumour clinicopathological features"],"prefix":"10.1038","volume":"97","author":[{"given":"K","family":"Harada","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Hiraoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Kato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Horii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"Sakaguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y","family":"Shiratori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,10,9]]},"reference":[{"key":"BF6604014_CR1","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1053\/j.gastro.2005.03.051","volume":"129","author":"K Akino","year":"2005","unstructured":"Akino K, Toyota M, Suzuki H, Mita H, Sasaki Y, Ohe-Toyota M, Issa JP, Hinoda Y, Imai K, Tokino T (2005) The Ras effector RASSF2 is a novel tumor-suppressor gene in human colorectal cancer. Gastroenterology 129: 156\u2013169","journal-title":"Gastroenterology"},{"key":"BF6604014_CR2","doi-asserted-by":"publisher","first-page":"3426","DOI":"10.1038\/sj.onc.1207486","volume":"23","author":"Y Aoyama","year":"2004","unstructured":"Aoyama Y, Avruch J, Zhang XF (2004) Nore1 inhibits tumor cell growth independent of Ras or the MST1\/2 kinases. Oncogene 23: 3426\u20133433","journal-title":"Oncogene"},{"key":"BF6604014_CR3","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s00384-006-0093-x","volume":"22","author":"C Azzoni","year":"2007","unstructured":"Azzoni C, Bottarelli L, Campanini N, Di Cola G, Bader G, Mazzeo A, Salvemini C, Morari S, Di Mauro D, Donadei E, Roncoroni L, Bordi C, Sarli L (2007) Distinct molecular patterns based on proximal and distal sporadic colorectal cancer: arguments for different mechanisms in the tumorigenesis. Int J Colorectal Dis 22: 115\u2013126","journal-title":"Int J Colorectal Dis"},{"key":"BF6604014_CR4","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1002\/cncr.21721","volume":"106","author":"EL Barry","year":"2006","unstructured":"Barry EL, Baron JA, Grau MV, Wallace K, Haile RW (2006) K-ras mutations in incident sporadic colorectal adenomas. Cancer 106: 1036\u20131040","journal-title":"Cancer"},{"key":"BF6604014_CR5","first-page":"665","volume":"18","author":"R Dammann","year":"2003","unstructured":"Dammann R, Schagdarsurengin U, Strunnikova M, Rastetter M, Seidel C, Liu L, Tommasi S, Pfeifer GP (2003) Epigenetic inactivation of the Ras-association domain family 1 (RASSF1A) gene and its function in human carcinogenesis. Histol Histopathol 18: 665\u2013677","journal-title":"Histol Histopathol"},{"key":"BF6604014_CR6","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1038\/nature00766","volume":"417","author":"H Davies","year":"2002","unstructured":"Davies H, Bignell GR, Cox C, Stephens P, Edkins S, Clegg S, Teague J (2002) Mutations of the BRAF gene in human cancer. Nature 417: 949\u2013954","journal-title":"Nature"},{"key":"BF6604014_CR7","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1002\/gcc.10310","volume":"39","author":"E Domingo","year":"2004","unstructured":"Domingo E, Espin E, Armengol M, Oliveira C, Pinto M, Duval A, Brennetot C, Seruca R, Hamelin R, Yamamoto H, Schwartz Jr S (2004) Activated BRAF targets proximal colon tumors with mismatch repair deficiency and MLH1 inactivation. Genes Chromosomes Cancer 39: 138\u2013142","journal-title":"Genes Chromosomes Cancer"},{"key":"BF6604014_CR8","doi-asserted-by":"publisher","first-page":"8688","DOI":"10.1158\/0008-5472.CAN-04-2065","volume":"64","author":"K Eckfeld","year":"2004","unstructured":"Eckfeld K, Hesson L, Vos MD, Bieche I, Latif F, Clark GJ (2004) RASSF4\/AD037 is a potential ras effector\/tumor suppressor of the RASSF family. Cancer Res 64: 8688\u20138693","journal-title":"Cancer Res"},{"key":"BF6604014_CR9","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1158\/1055-9965.EPI-06-0144","volume":"15","author":"JG Einspahr","year":"2006","unstructured":"Einspahr JG, Martinez ME, Jiang R, Hsu CH, Rashid A, Bhattacharrya AK, Ahnen DJ, Jacobs ET, Houlihan PS, Webb CR, Alberts DS, Hamilton SR (2006) Associations of Ki-ras proto-oncogene mutation and p53 gene overexpression in sporadic colorectal adenomas with demographic and clinicopathologic characteristics. Cancer Epidemiol Biomarkers Prev 15: 1443\u20131450","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"BF6604014_CR10","doi-asserted-by":"publisher","first-page":"3934","DOI":"10.1038\/sj.onc.1209422","volume":"25","author":"FS Falvella","year":"2006","unstructured":"Falvella FS, Manenti G, Spinola M, Pignatiello C, Conti B, Pastorino U, Dragani TA (2006) Identification of RASSF8 as a candidate lung tumor suppressor gene. Oncogene 25: 3934\u20133938","journal-title":"Oncogene"},{"key":"BF6604014_CR11","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/0092-8674(90)90186-I","volume":"61","author":"ER Fearon","year":"1990","unstructured":"Fearon ER, Vogelstein B (1990) A genetic model for colorectal tumorigenesis. Cell 61: 759\u2013767","journal-title":"Cell"},{"key":"BF6604014_CR12","doi-asserted-by":"publisher","first-page":"4015","DOI":"10.1158\/1078-0432.CCR-04-0031","volume":"10","author":"M Frattini","year":"2004","unstructured":"Frattini M, Balestra D, Suardi S, Oggionni M, Alberici P, Radice P, Costa A, Daidone MG, Leo E, Pilotti S, Bertario L, Pierotti MA (2004) Different genetic features associated with colon and rectal carcinogenesis. Clin Cancer Res 10: 4015\u20134021","journal-title":"Clin Cancer Res"},{"key":"BF6604014_CR13","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/BF02234301","volume":"44","author":"EC Gonzalez","year":"2001","unstructured":"Gonzalez EC, Roetzheim RG, Ferrante JM, Campbell R (2001) Predictors of proximal vs. distal colorectal cancers. Dis Colon Rectum 44: 251\u2013258","journal-title":"Dis Colon Rectum"},{"key":"BF6604014_CR14","doi-asserted-by":"publisher","first-page":"3987","DOI":"10.1038\/sj.onc.1208566","volume":"24","author":"LB Hesson","year":"2005","unstructured":"Hesson LB, Wilson R, Morton D, Adams C, Walker M, Maher ER, Latif F (2005) CpG island promoter hypermethylation of a novel Ras-effector gene RASSF2A is an early event in colon carcinogenesis and correlates inversely with K-ras mutations. Oncogene 24: 3987\u20133994","journal-title":"Oncogene"},{"key":"BF6604014_CR15","first-page":"522","volume":"60","author":"E Hidaka","year":"2000","unstructured":"Hidaka E, Yanagisawa A, Seki M, Takano K, Setoguchi T, Kato Y (2000) High frequency of K-ras mutations in biliary duct carcinomas of cases with a long common channel in the papilla of Vater. Cancer Res 60: 522\u2013524","journal-title":"Cancer Res"},{"key":"BF6604014_CR16","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1053\/j.gastro.2006.04.027","volume":"131","author":"S Hiraoka","year":"2006","unstructured":"Hiraoka S, Kato J, Tatsukawa M, Harada K, Fujita H, Morikawa T, Shiraha H, Shiratori Y (2006) Laterally spreading type of colorectal adenoma exhibits a unique methylation phenotype and K-ras mutations. Gastroenterology 131: 379\u2013389","journal-title":"Gastroenterology"},{"key":"BF6604014_CR17","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1002\/ijc.10635","volume":"101","author":"B Iacopetta","year":"2002","unstructured":"Iacopetta B (2002) Are there two sides to colorectal cancer? Int J Cancer 101: 403\u2013408","journal-title":"Int J Cancer"},{"key":"BF6604014_CR18","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1136\/gut.2003.037671","volume":"53","author":"T Kambara","year":"2004","unstructured":"Kambara T, Simms LA, Whitehall VL, Spring KJ, Wynter CV, Walsh MD, Barker MA, Arnold S, McGivern A, Matsubara N, Tanaka N, Higuchi T, Young J, Jass JR, Leggett BA (2004) BRAF mutation is associated with DNA methylation in serrated polyps and cancers of the colorectum. Gut 53: 1137\u20131144","journal-title":"Gut"},{"key":"BF6604014_CR19","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1186\/1471-2407-6-211","volume":"6","author":"TD Kim","year":"2006","unstructured":"Kim TD, Song KS, Li G, Choi H, Park HD, Lim K, Hwang BD, Yoon WH (2006) Activity and expression of urokinase-type plasminogen activator and matrix metalloproteinases in human colorectal cancer. BMC Cancer 6: 211","journal-title":"BMC Cancer"},{"key":"BF6604014_CR20","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/S0092-8674(00)81333-1","volume":"87","author":"KW Kinzler","year":"1996","unstructured":"Kinzler KW, Vogelstein B (1996) Lessons from hereditary colorectal cancer. Cell 87: 159\u2013170","journal-title":"Cell"},{"key":"BF6604014_CR21","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1007\/s002689900293","volume":"21","author":"S Kudo","year":"1997","unstructured":"Kudo S, Kashida H, Nakajima T, Tamura S, Nakajo K (1997) Endoscopic diagnosis and treatment of early colorectal cancer. World J Surg 21: 694\u2013701","journal-title":"World J Surg"},{"key":"BF6604014_CR22","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1476-4598-5-2","volume":"5","author":"WQ Li","year":"2006","unstructured":"Li WQ, Kawakami K, Ruszkiewicz A, Bennett G, Moore J, Iacopetta B (2006) BRAF mutations are associated with distinctive clinical, pathological and molecular features of colorectal cancer independently of microsatellite instability status. Mol Cancer 5: 2","journal-title":"Mol Cancer"},{"key":"BF6604014_CR23","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1186\/1471-2407-5-160","volume":"5","author":"M Luchtenborg","year":"2005","unstructured":"Luchtenborg M, Weijenberg MP, Wark PA, Saritas AM, Roemen GM, van Muijen GN, de Bruine AP, van den Brandt PA, de Goeij AF (2005) Mutations in APC, CTNNB1 and K-ras genes and expression of hMLH1 in sporadic colorectal carcinomas from the Netherlands Cohort Study. BMC Cancer 5: 160","journal-title":"BMC Cancer"},{"key":"BF6604014_CR24","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1053\/gast.2001.26278","volume":"121","author":"T Maltzman","year":"2001","unstructured":"Maltzman T, Knoll K, Martinez ME, Byers T, Stevens BR, Marshall JR, Reid ME, Einspahr J, Hart N, Bhattacharyya AK, Kramer CB, Sampliner R, Alberts DS, Ahnen DJ (2001) Ki-ras proto-oncogene mutations in sporadic colorectal adenomas: relationship to histologic and clinical characteristics. Gastroenterology 121: 302\u2013309","journal-title":"Gastroenterology"},{"key":"BF6604014_CR25","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1038\/nrc1097","volume":"3","author":"M Malumbres","year":"2003","unstructured":"Malumbres M, Barbacid M (2003) RAS oncogenes: the first 30 years. Nat Rev Cancer 3: 459\u2013465","journal-title":"Nat Rev Cancer"},{"key":"BF6604014_CR26","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1136\/gut.2005.082859","volume":"55","author":"P Minoo","year":"2006","unstructured":"Minoo P, Baker K, Goswami R, Chong G, Foulkes WD, Ruszkiewicz AR, Barker M, Buchanan D, Young J, Jass JR (2006) Extensive DNA methylation in normal colorectal mucosa in hyperplastic polyposis. Gut 55: 1467\u20131474","journal-title":"Gut"},{"key":"BF6604014_CR27","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1038\/sj.bjc.6603337","volume":"95","author":"E Miranda","year":"2006","unstructured":"Miranda E, Destro A, Malesci A, Balladore E, Bianchi P, Baryshnikova E, Franchi G, Morenghi E, Laghi L, Gennari L, Roncalli M (2006) Genetic and epigenetic changes in primary metastatic and nonmetastatic colorectal cancer. Br J Cancer 95: 1101\u20131107","journal-title":"Br J Cancer"},{"key":"BF6604014_CR28","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1097\/00000478-200404000-00001","volume":"28","author":"MJ O\u2019Brien","year":"2004","unstructured":"O\u2019Brien MJ, Yang S, Clebanoff JL, Mulcahy E, Farraye FA, Amorosino M, Swan N (2004) Hyperplastic (serrated) polyps of the colorectum: relationship of CpG island methylator phenotype and K-ras mutation to location and histologic subtype. Am J Surg Pathol 28: 423\u2013434","journal-title":"Am J Surg Pathol"},{"key":"BF6604014_CR29","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s10350-004-0754-1","volume":"48","author":"M Okamoto","year":"2005","unstructured":"Okamoto M, Kawabe T, Yamaji Y, Kato J, Ikenoue T, Togo G, Watabe H, Yoshida H, Shiratori Y, Omata M (2005) Flat-type early colorectal cancer preferentially develops in right-sided colon in older patients. Dis Colon Rectum 48: 101\u2013107","journal-title":"Dis Colon Rectum"},{"key":"BF6604014_CR30","doi-asserted-by":"publisher","first-page":"7630","DOI":"10.1038\/sj.onc.1208906","volume":"24","author":"C Oliveira","year":"2005","unstructured":"Oliveira C, Velho S, Domingo E, Preto A, Hofstra RM, Hamelin R, Yamamoto H, Seruca R, Schwartz Jr S (2005) Concomitant RASSF1A hypermethylation and KRAS\/BRAF mutations occur preferentially in MSI sporadic colorectal cancer. Oncogene 24: 7630\u20137634","journal-title":"Oncogene"},{"key":"BF6604014_CR31","doi-asserted-by":"publisher","first-page":"2267","DOI":"10.1126\/science.1103233","volume":"306","author":"E O\u2019Neill","year":"2004","unstructured":"O\u2019Neill E, Rushworth L, Baccarini M, Kolch W (2004) Role of the kinase MST2 in suppression of apoptosis by the proto-oncogene product Raf-1. Science 306: 2267\u20132270","journal-title":"Science"},{"key":"BF6604014_CR32","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1002\/ijc.22276","volume":"120","author":"HW Park","year":"2006","unstructured":"Park HW, Kang HC, Kim IJ, Jang SG, Kim K, Yoon HJ, Jeong SY, Park JG (2006) Correlation between hypermethylation of the RASSF2A promoter and K-ras\/BRAF mutations in microsatellite-stable colorectal cancers. Int J Cancer 120: 7\u201312","journal-title":"Int J Cancer"},{"key":"BF6604014_CR33","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/S0002-9440(10)63878-3","volume":"162","author":"SJ Park","year":"2003","unstructured":"Park SJ, Rashid A, Lee JH, Kim SG, Hamilton SR, Wu TT (2003) Frequent CpG island methylation in serrated adenomas of the colorectum. Am J Pathol 162: 815\u2013822","journal-title":"Am J Pathol"},{"key":"BF6604014_CR34","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1038\/418934a","volume":"418","author":"H Rajagopalan","year":"2002","unstructured":"Rajagopalan H, Bardelli A, Lengauer C, Kinzler KW, Vogelstein B, Velculescu VE (2002) Tumorigenesis: RAF\/RAS oncogenes and mismatch-repair status. Nature 418: 934","journal-title":"Nature"},{"key":"BF6604014_CR35","doi-asserted-by":"publisher","first-page":"8900","DOI":"10.1038\/sj.onc.1207993","volume":"23","author":"N Sakamoto","year":"2004","unstructured":"Sakamoto N, Terai T, Ajioka Y, Abe S, Kobayasi O, Hirai S, Hino O, Watanabe H, Sato N, Shimoda T, Fujii H (2004) Frequent hypermethylation of RASSF1A in early flat-type colorectal tumors. Oncogene 23: 8900\u20138907","journal-title":"Oncogene"},{"key":"BF6604014_CR36","first-page":"1193","volume":"9","author":"WS Samowitz","year":"2000","unstructured":"Samowitz WS, Curtin K, Schaffer D, Robertson M, Leppert M, Slattery ML (2000) Relationship of Ki-ras mutations in colon cancers to tumor location, stage, and survival: a population-based study. Cancer Epidemiol Biomarkers Prev 9: 1193\u20131197","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"BF6604014_CR37","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1158\/0008-5472.CAN-05-2625","volume":"66","author":"S Toyooka","year":"2006","unstructured":"Toyooka S, Tokumo M, Shigematsu H, Matsuo K, Asano H, Tomii K, Ichihara S, Suzuki M, Aoe M, Date H, Gazdar AF, Shimizu N (2006) Mutational and epigenetic evidence for independent pathways for lung adenocarcinomas arising in smokers and never smokers. Cancer Res 66: 1371\u20131375","journal-title":"Cancer Res"},{"key":"BF6604014_CR38","doi-asserted-by":"publisher","first-page":"3792","DOI":"10.1038\/sj.onc.1205466","volume":"21","author":"M van Engeland","year":"2002","unstructured":"van Engeland M, Roemen GM, Brink M, Pachen MM, Weijenberg MP, de Bruine AP, Arends JW, van den Brandt PA, de Goeij AF, Herman JG (2002) K-ras mutations and RASSF1A promoter methylation in colorectal cancer. Oncogene 21: 3792\u20133795","journal-title":"Oncogene"},{"key":"BF6604014_CR39","doi-asserted-by":"publisher","first-page":"28045","DOI":"10.1074\/jbc.M300554200","volume":"278","author":"MD Vos","year":"2003","unstructured":"Vos MD, Ellis CA, Elam C, Ulku AS, Taylor BJ, Clark GJ (2003) RASSF2 is a novel K-Ras-specific effector and potential tumor suppressor. J Biol Chem 278: 28045\u201328051","journal-title":"J Biol Chem"},{"key":"BF6604014_CR40","doi-asserted-by":"publisher","first-page":"7277","DOI":"10.1038\/sj.onc.1205922","volume":"21","author":"KJ Wagner","year":"2002","unstructured":"Wagner KJ, Cooper WN, Grundy RG, Caldwell G, Jones C, Wadey RB, Morton D, Schofield PN, Reik W, Latif F, Maher ER (2002) Frequent RASSF1A tumour suppressor gene promoter methylation in Wilms\u2019 tumour and colorectal cancer. Oncogene 21: 7277\u20137282","journal-title":"Oncogene"},{"key":"BF6604014_CR41","first-page":"6451","volume":"62","author":"ST Yuen","year":"2002","unstructured":"Yuen ST, Davies H, Chan TL, Ho JW, Bignell GR, Cox C, Stephens P, Edkins S, Tsui WW, Chan AS, Futreal PA, Stratton MR, Wooster R, Leung SY (2002) Similarity of the phenotypic patterns associated with BRAF and KRAS mutations in colorectal neoplasia. Cancer Res 62: 6451\u20136455","journal-title":"Cancer Res"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/6604014.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6604014","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6604014.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T12:29:21Z","timestamp":1684412961000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/6604014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,10,9]]},"references-count":41,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2007,11]]}},"alternative-id":["BF6604014"],"URL":"https:\/\/doi.org\/10.1038\/sj.bjc.6604014","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,10,9]]}}}